Sunday, October 11, 2026

Woodward to Launch A350 Wing Actuator Production in November 2028 as Global Wide-Body Demand Rises

Woodward will begin producing wing spoiler actuators for Airbus A350 aircraft in November 2028, supporting the European manufacturer's expansion amid rising global demand for fuel-efficient long-haul jets. The US-based aerospace supplier announced 7-12% sales growth targets and a $1.8 billion share repurchase plan. The production launch addresses supply chain needs as Airbus ramps A350 output to serve airlines worldwide.

Source Trace Score1 source document1 with a live linkVerifiability: Basic
Woodward to Launch A350 Wing Actuator Production in November 2028 as Global Wide-Body Demand Rises
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Woodward will start manufacturing wing spoiler actuators for the Airbus A350 in November 2028, the US aerospace component supplier announced. The actuators will ship directly to Airbus assembly lines in Europe.

The production timeline aligns with Airbus's A350 program expansion as airlines globally order fuel-efficient wide-body aircraft for long-haul routes. Airbus holds over 500 A350 orders in backlog across its -900 and -1000 variants, with major customers including Qatar Airways, Singapore Airlines, and Cathay Pacific.

Wing spoiler actuators control movable wing surfaces that manage lift and drag during flight. The A350 uses multiple spoiler systems across its wings for precise control during takeoff, landing, and cruise operations.

Woodward outlined 7-12% sales growth targets alongside a $1.8 billion share repurchase plan, signaling confidence in global aerospace recovery. The company supplies flight control systems and engine components to aircraft manufacturers in North America, Europe, and Asia.

Global aerospace manufacturing has rebounded from pandemic disruption. Airbus delivered 735 commercial aircraft in 2023 and is increasing production across single-aisle and wide-body programs. The A350 competes with Boeing's 787 Dreamliner in the twin-engine wide-body market serving intercontinental routes.

Supply chain coordination is critical as aircraft manufacturers worldwide accelerate production. Component suppliers must align manufacturing capacity with airframer schedules to prevent bottlenecks. Woodward's actuator production launch demonstrates supplier readiness for increased A350 output.

Over 500 A350s operate globally since the aircraft entered service in 2015. Airlines choose the A350 for routes connecting Asia-Pacific hubs, European cities, and North American destinations. The aircraft offers 25% lower operating costs than older wide-body models.

Woodward operates manufacturing facilities in the US and Europe, supporting both American and European aerospace programs. The company employs over 9,000 workers across aerospace and industrial divisions globally.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleSeeking Alpha· November 25, 2025
    Woodward outlines 7–12% sales growth target and $1.8B share repurchase plan as automation, aerospace wins drive 2026 outlook
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com